As of 28 Aug 2026, Indo US Bio-Tech Ltd share price is ₹82.00. The stock opened at ₹82.00 and had closed at ₹81.36 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹75.70 and a high of ₹158.85. In terms of performance, Indo US Bio-Tech Ltd share price has decreased by 39.95% over the past six months and has decreased by 44.93% over the last year.
INDOUS Charts
Indo US Bio-Tech Ltd Overview
About INDOUS
Indo US Bio-Tech Ahmedabad is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds. The Company has c product range of Field crops and Vegetable crops.
Indo US Bio-Tech Ltd Historical Performance
Indo US Bio-Tech Ltd Fundamental Analysis
Indo US Bio-Tech Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 33.11 | 26.04 | 22.81 | 30.88 | 30.77 |
| EBITDA | 4.09 | 3.25 | 4.15 | 4.19 | 5.47 |
| Net Profit | 3.04 | 1.97 | 3.00 | 3.45 | 4.70 |
| EPS | 1.51 | 0.98 | 1.49 | 1.72 | 2.35 |
Indo US Bio-Tech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 41.62 |
| MACD | -0.60 |
| 20-Day SMA | 82.84 |
Indo US Bio-Tech Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Indo US Bio-Tech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Hindustan Unilever LtdHINDUNILVR | ₹2,009.00-0.59% | ₹5,31,630.27 | 36.57 | 22.41% |
| ITC LtdITC | ₹269.00-0.46% | ₹3,90,911.96 | 11.06 | 28.53% |
| Nestle India LtdNESTLEIND | ₹1,450.00-0.10% | ₹2,39,998 | 73.60 | 67.85% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Indo US Bio-Tech Ltd today is ₹82.00 on NSE and ₹82.00 on BSE.
- The 52-week high of Indo US Bio-Tech Ltd is ₹158.85, while the 52-week low is ₹75.70.
- The current market capitalisation of Indo US Bio-Tech Ltd is approximately ₹163 crore.
- The P/E (Price-to-Earnings) ratio of Indo US Bio-Tech Ltd is 14.25. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Indo US Bio-Tech Ltd is 1.76. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Indo US Bio-Tech Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Indo US Bio-Tech Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Indo US Bio-Tech Ltd has delivered a return of approximately -69.90%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Indo US Bio-Tech Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 68.29% promoters, 0.01% FIIs, 0.00% DIIs, and 24.51% public shareholders.
